Healthcare
Sino Biopharmaceutical profit up 16.8% to HK$320mln
Sino Biopharmaceutical profit up 16.8% to HK$320mln
The company strengthens its quality control and product development to enhance the competitiveness of its products and brand.
MicroPort raises HK$1.5bln in Hong Kong IPO
Proceeds will be used to develop new products, acquire businesses and expand company’s production facilities.
Shanghai Pharma to raise $1.2bln via HK IPO
Company to offer 25% stake to fund acquisition of rivals and sales networks.
Read Here
Advertise
Sign Up
Commentary
Reinsurance beyond borders: How Hong Kong can strengthen Asia’s risk-sharing architecture
Hong Kong hospitality insights: Robust investment, tourism expansion, and operational recovery
Hong Kong’s insurance boom is facing a financing test
In the age of AI, creativity is the decisive advantage
Hong Kong cleared stablecoins for take-off. Getting them to work across Asia is the hard part